159 related articles for article (PubMed ID: 36619553)
1. Relationship between serum NDRG3 and papillary thyroid carcinoma.
Wang J; Wang J; Quan J; Liu J; Tian L; Dong C
Front Endocrinol (Lausanne); 2022; 13():1091462. PubMed ID: 36619553
[TBL] [Abstract][Full Text] [Related]
2. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
[TBL] [Abstract][Full Text] [Related]
3. Utility of high b-value (2000 sec/mm2) DWI with RESOLVE in differentiating papillary thyroid carcinomas and papillary thyroid microcarcinomas from benign thyroid nodules.
Wang Q; Guo Y; Zhang J; Shi L; Ning H; Zhang X; Lu Y
PLoS One; 2018; 13(7):e0200270. PubMed ID: 30020961
[TBL] [Abstract][Full Text] [Related]
4. Focal Lymphocytic Thyroiditis Nodules Share the Features of Papillary Thyroid Cancer on Ultrasound.
Hwang S; Shin DY; Kim EK; Yang WI; Byun JW; Lee SJ; Kim G; Im SJ; Lee EJ
Yonsei Med J; 2015 Sep; 56(5):1338-44. PubMed ID: 26256977
[TBL] [Abstract][Full Text] [Related]
5. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
[TBL] [Abstract][Full Text] [Related]
6. Fine Needle Aspiration Cytology and Thyroglobulin Antibodies in Preoperative Diagnosis of Thyroid Malignancy.
Hasukic B; Jakubovic-Cickusic A; Sehanovic E; Osmic H
Med Arch; 2019 Dec; 73(6):382-385. PubMed ID: 32082004
[TBL] [Abstract][Full Text] [Related]
7. Thyroglobulin antibodies as a potential predictive marker of papillary thyroid carcinoma in patients with indeterminate cytology.
Karatzas T; Vasileiadis I; Zapanti E; Charitoudis G; Karakostas E; Boutzios G
Am J Surg; 2016 Nov; 212(5):946-952. PubMed ID: 27324384
[TBL] [Abstract][Full Text] [Related]
8. The Inverse Association of Serum Magnesium with Papillary Thyroid Cancer in Thyroid Nodules: a Cross-Sectional Survey Based on Thyroidectomy Population.
Xu H; Hu X; Li J; Nie Z; Kang S; Liu H; Wang Y; Jia X; Lyu Z
Biol Trace Elem Res; 2023 Jul; 201(7):3279-3289. PubMed ID: 36227448
[TBL] [Abstract][Full Text] [Related]
9. Thyroglobulin level in fine-needle aspirates for preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: two different cutoff values according to serum thyroglobulin level.
Jeon MJ; Kim WG; Jang EK; Choi YM; Lee YM; Sung TY; Yoon JH; Chung KW; Hong SJ; Baek JH; Lee JH; Kim TY; Shong YK; Kim WB
Thyroid; 2015 Apr; 25(4):410-6. PubMed ID: 25607926
[TBL] [Abstract][Full Text] [Related]
10. The anteroposterior diameter of nodules in the risk assessment of papillary thyroid microcarcinoma.
Huang K; Gao N; Zhai Q; Bian D; Wang D; Wang X
Medicine (Baltimore); 2018 Mar; 97(10):e9712. PubMed ID: 29517693
[TBL] [Abstract][Full Text] [Related]
11. Differentiation between malignant and benign thyroid nodules and stratification of papillary thyroid cancer with aggressive histological features: Whole-lesion diffusion-weighted imaging histogram analysis.
Hao Y; Pan C; Chen W; Li T; Zhu W; Qi J
J Magn Reson Imaging; 2016 Dec; 44(6):1546-1555. PubMed ID: 27093648
[TBL] [Abstract][Full Text] [Related]
12. Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules.
Zhang A; Wang C; Lu H; Chen X; Ba Y; Zhang C; Zhang CY
Dis Markers; 2019; 2019():3717683. PubMed ID: 31636734
[TBL] [Abstract][Full Text] [Related]
13. The application value of CDFI and SMI combined with serological markers in distinguishing benign and malignant thyroid nodules.
Li F; Sun W; Liu L; Meng Z; Su J
Clin Transl Oncol; 2022 Nov; 24(11):2200-2209. PubMed ID: 35792982
[TBL] [Abstract][Full Text] [Related]
14. Phantom experiment and clinical utility of quantitative shear wave elastography for differentiating thyroid nodules.
Fukuhara T; Matsuda E; Fujiwara K; Tanimura C; Izawa S; Kataoka H; Kitano H
Endocr J; 2014; 61(6):615-21. PubMed ID: 24717719
[TBL] [Abstract][Full Text] [Related]
15. Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules.
Saleh HA; Jin B; Barnwell J; Alzohaili O
Diagn Pathol; 2010 Jan; 5():9. PubMed ID: 20181018
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer.
Wu X; Lun Y; Jiang H; Gang Q; Xin S; Duan Z; Zhang J
Endocrine; 2014 Aug; 46(3):554-60. PubMed ID: 24338678
[TBL] [Abstract][Full Text] [Related]
17. Autoantibody against WD repeat domain 1 is a novel serological biomarker for screening of thyroid neoplasia.
Izawa S; Okamura T; Matsuzawa K; Ohkura T; Ohkura H; Ishiguro K; Noh JY; Kamijo K; Yoshida A; Shigemasa C; Kato M; Yamamoto K; Taniguchi S
Clin Endocrinol (Oxf); 2013 Jul; 79(1):35-42. PubMed ID: 23215816
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic significance of elevated expression of HBME-1 in papillary thyroid carcinoma.
Chen YJ; Zhao RM; Zhao Q; Li BY; Ma QY; Li X; Chen X
Tumour Biol; 2016 Jul; 37(7):8715-20. PubMed ID: 26738867
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of papillary thyroid carcinoma and possible papillary thyroid carcinoma-related benign thyroid nodules.
Mai KT; Ford JC; Yazdi HM; Perkins DG; Commons AS
Pathol Res Pract; 2000; 196(8):533-40. PubMed ID: 10982016
[TBL] [Abstract][Full Text] [Related]
20. Preoperative platelet distribution width-to-platelet ratio combined with serum thyroglobulin may be objective and popularizable indicators in predicting papillary thyroid carcinoma.
Jin J; Wu G; Ruan C; Ling H; Zheng X; Ying C; Zhang Y
J Clin Lab Anal; 2022 Jun; 36(6):e24443. PubMed ID: 35441746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
